Clinical Development
Resource Center.
Clinical development is changing. This Resource Center explains the thinking behind PrismCDM, the emerging category of Trial Intelligence, and the engineering principles that make regulated AI trustworthy. Whether you are evaluating platforms, educating your team, or reviewing our methodology, start here.
If you read only one resource, read this first.
Why Not Just Use AI?
AI Assistant vs Clinical Operating System. A category-level read on why regulated clinical development requires more than an AI tool.
Understand the category PrismCDM created and why it exists.
What Trial Intelligence is, what it is not, and the executive frame for evaluating any clinical operating system. Best for the leaders setting the evaluation criteria.
- Available
Why Not Just Use AI?
AI Assistant vs Clinical Operating System. A category-level read on why regulated clinical development requires more than an AI tool.
Best ForExecutives10 min readRead - Available
What Is Trial Intelligence?
Understand the category PrismCDM created and why it exists. Distinguishes Trial Intelligence from protocol search, generic AI assistants, and traditional CDM platforms.
Best ForClinical Operations8 min readRead
Understand the platform.
What PrismCDM produces, how the Brief is structured, who reads it, and what evaluation actually looks like. Best for the team that will use PrismCDM day to day.
- Available
Trial Intelligence Brief Guide
What a Brief is, what it includes, who reads it, and how it fits into the operational workflow.
Best ForEnd Users12 min readRead - Available
FAQ
The most-asked buyer questions. Compliance, security, integrations, deployment options, and what evaluation looks like.
Best ForProcurement7 min readRead
Understand how PrismCDM works.
The methodology and engineering principles. Composite scoring, evidence classification, identity, integrity anchors, the engine versioning stack, and the architectural reason invented data is structurally impossible. Best for technical buyers, security review, and methodology partners.